Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;92(11):2409-2411.
doi: 10.1002/jmv.26097. Epub 2020 Jun 9.

Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19

Nurshad Ali  1
Affiliations

Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19

Nurshad Ali. J Med Virol. 2020 Nov.
No abstract available

PubMed Disclaimer

References

    1. Tan C, Huang Y, Shi F, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. J Med Virol. 2020. 10.1002/jmv.25871 - DOI - PMC - PubMed
    1. Tian W, Jiang W, Yao J, et al. Predictors of mortality in hospitalized COVID‐19 patients: asystematic review and meta‐analysis. J Med Virol. 2020. 10.1002/jmv.26050 - DOI - PMC - PubMed
    1. Wang G, Wu C, Zhang Q, et al. C‐reactive protein level may predict the risk of COVID‐19 aggravation. Open Forum Infect Dis. 2020;7(5). 10.1093/ofid/ofaa153 - DOI - PMC - PubMed
    1. Ali N. Is SARS‐CoV‐2 associated with liver dysfunction in COVID‐19 patients? Clin Res Hepatol Gastroenterol. 2020. 10.1016/j.clinre.2020.05.002 - DOI - PMC - PubMed
    1. Lagunas‐Rangel FA. Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis. J Med Virol. 2020. 10.1002/jmv.25819 - DOI - PMC - PubMed